Annual Cash & Cash Equivalents
$297.17M$199.31M+203.66%
Summary
- Current Value
- As of today, AKTS annual cash & cash equivalents is $297.17M, up +203.66% on
- Historical Performance
- AKTS annual cash & cash equivalents is up +131.08% over the past 3 years, and up +131.08% over the past 5 years
- All-Time High Comparison
- AKTS annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- AKTS annual cash & cash equivalents is +203.66% above its 3-year low of $97.86M reached on
- Sector Comparison
- AKTS annual cash & cash equivalents is higher than 83.53% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $297.17M | +203.7% | +131.1% | +131.1% | +131.1% | |
| Quarterly Cash & Cash Equivalents | $180.25M | -19.8% | -19.8% | -19.8% | -19.8% | |
| Price | $19.64 | – | – | – | – | |
| Annual Current Assets | - | – | – | – | – | |
| Annual Total Liabilities | - | – | – | – | – | |
| Annual Working Capital | - | – | – | – | – | |
| Annual Net Income | - | – | – | – | – |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $297.17M | at high | |
| 5Y | $297.17M | at high | |
| All | $297.17M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $97.86M | +203.7% | |
| 5Y | $97.86M | +203.7% | |
| All | $97.86M | +203.7% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $297.17M | +203.7% | |
| $97.86M | -23.9% |
| Year | Value | Change |
|---|---|---|
| $128.60M | - |
FAQ
What is the current annual cash & cash equivalents of AKTS?
As of today, AKTS annual cash & cash equivalents is $297.17M
What is 1-year change in AKTS annual cash & cash equivalents?
AKTS annual cash & cash equivalents is up +203.66% year-over-year
What is 3-year change in AKTS annual cash & cash equivalents?
AKTS annual cash & cash equivalents is up +131.08% over the past 3 years
How far is AKTS annual cash & cash equivalents from its all-time high?
AKTS annual cash & cash equivalents is currently at its all-time high
How does AKTS annual cash & cash equivalents rank versus sector peers?
AKTS annual cash & cash equivalents is higher than 83.53% of companies in Healthcare sector
When is AKTS next annual earnings release?
The next annual earnings release for AKTS is on
Quarterly Cash & Cash Equivalents
$180.25M$116.92M-39.34%
Summary
- Current Value
- As of today, AKTS quarterly cash & cash equivalents is $180.25M, down -39.34% on
- Historical Performance
- AKTS quarterly cash & cash equivalents is down -19.76% year-over-year, and down -19.76% over the past 3 years
- All-Time High Comparison
- AKTS quarterly cash & cash equivalents is currently -39.34% below its historical high of $297.17M set on
- 3-Year Low Comparison
- AKTS quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- AKTS quarterly cash & cash equivalents is higher than 67.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $180.25M | 0.0% | -19.8% | -19.8% | -19.8% | |
| Annual Cash & Cash Equivalents | $297.17M | – | +203.7% | +131.1% | +131.1% | |
| Price | $19.64 | – | – | – | – | |
| Quarterly Current Assets | $249.42M | 0.0% | -20.9% | -20.9% | -20.9% | |
| Quarterly Total Liabilities | $411.43M | 0.0% | -0.6% | -0.6% | -0.6% | |
| Quarterly Working Capital | $222.51M | 0.0% | -25.4% | -25.4% | -25.4% | |
| Quarterly Net Income | - | – | – | – | – |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $297.17M | N/A | -39.3% |
| 3Y | $297.17M | -39.3% | |
| 5Y | $297.17M | -39.3% | |
| All | $297.17M | -39.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $180.25M | at low | |
| 3Y | $180.25M | at low | |
| 5Y | $180.25M | at low | |
| All | $180.25M | at low |
Quarterly Cash & Cash Equivalents History
| Month | Value | Change |
|---|---|---|
| $180.25M | -39.3% | |
| $297.17M | +32.3% |
| Month | Value | Change |
|---|---|---|
| $224.64M | - |
FAQ
What is the current quarterly cash & cash equivalents of AKTS?
As of today, AKTS quarterly cash & cash equivalents is $180.25M
What is AKTS quarterly cash & cash equivalents most recent change?
AKTS quarterly cash & cash equivalents was down -39.34% on September 30, 2025
What is 1-year change in AKTS quarterly cash & cash equivalents?
AKTS quarterly cash & cash equivalents is down -19.76% year-over-year
How far is AKTS quarterly cash & cash equivalents from its all-time high?
AKTS quarterly cash & cash equivalents is currently -39.34% below its historical high of $297.17M set on December 1, 2024
How does AKTS quarterly cash & cash equivalents rank versus sector peers?
AKTS quarterly cash & cash equivalents is higher than 67.21% of companies in Healthcare sector
When is AKTS next earnings release?
The next earnings release for AKTS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- AKTS Official Website www.aktisoncology.com
- AKTS Profile on Yahoo Finance finance.yahoo.com/quote/AKTS
- AKTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akts